Drug shortage
Silodosin Capsule · AbbVie Inc.
FDA drug shortage · To Be Discontinued · updated Feb 20, 2025
Key facts
| Generic name | Silodosin Capsule |
|---|---|
| Proprietary name | Rapaflo |
| Company | AbbVie Inc. |
| Presentation | Rapaflo, Capsule, 8 mg (NDC 0023-6142-30) |
| Dosage form | Capsule |
| Strength | 8 mg |
| Status | To Be Discontinued |
| Therapeutic category | Urology |
| Package NDCs | 0023-6142-30 |
| First posted | Feb 20, 2025 |
| Last updated | Feb 20, 2025 |
| Discontinued | Feb 20, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: